Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500
Closed -$1K 836
2022
Q3
$1K Hold
500
﹤0.01% 793
2022
Q2
$2K Hold
500
﹤0.01% 769
2022
Q1
$3K Hold
500
﹤0.01% 777
2021
Q4
$3K Hold
500
﹤0.01% 769
2021
Q3
$4K Hold
500
﹤0.01% 766
2021
Q2
$4K Hold
500
﹤0.01% 836
2021
Q1
$3K Sell
500
-100
-17% -$769 ﹤0.01% 857
2020
Q4
$3K Sell
600
-800
-57% -$5.09K ﹤0.01% 819
2020
Q3
$9K Buy
1,400
+1,100
+367% +$9.8K ﹤0.01% 716
2020
Q2
$3K Buy
+300
New +$862 ﹤0.01% 796

Other funds holding VXRT

Optimum Investment Advisors's VXRT Position: Q4 2022 in Review

Optimum Investment Advisors sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 500 shares — an estimated $1K sold.

Optimum Investment Advisors first reported a position in VXRT in Q2 2020 and held it in 10 quarters. The position peaked at $9K in Q3 2020. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • Optimum Investment Advisors reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 500 Vaxart shares in Q4 2022, an estimated $1K.
  • Optimum Investment Advisors first reported a position in Vaxart in Q2 2020 and held it in 10 quarters.
  • Optimum Investment Advisors's Vaxart position peaked at $9K in Q3 2020.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Optimum Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.